SEC Comment Letter for TRANSENTERIX, INC. (TRXDW) (CIK 0000876378) — Feb 12, 2020
TRANSENTERIX, INC. (TRXDW) (CIK 0000876378)
Date: Feb. 12, 2020 · CIK: 0000876378 · Accession: 0000000000-20-001327
AI Filing Summary & Sentiment
File numbers found in text: 333-236337
Letter
February 12, 2020 Brett Farabaugh Interim Chief Financial Officer TransEnterix, Inc. 635 Davis Drive, Suite 300 Morrisville, NC 27560 Re:TransEnterix, Inc. Registration Statement on Form S-3 Filed February 7, 2020 File No. 333-236337 Dear Mr. Farabaugh: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary J. Mullany, Esquire
Show Raw Text
February 12, 2020
Brett Farabaugh
Interim Chief Financial Officer
TransEnterix, Inc.
635 Davis Drive, Suite 300
Morrisville, NC 27560
Re:TransEnterix, Inc.
Registration Statement on Form S-3
Filed February 7, 2020
File No. 333-236337
Dear Mr. Farabaugh:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary J. Mullany, Esquire